You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Negative symptom

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Earthquake Trial in Gaziantep (Group included in a psychoeducational program based on the cognitive behavioral approach

Not yet recruiting
  • Earthquake
  • Group included in a psychoeducational program based on the cognitive behavioral approach (experiment)
  • Gaziantep, Turkey
    Gaziantep University
Sep 21, 2023

Schizophrenia Trial (asenapine, olanzapine)

Completed
Has Results
  • Schizophrenia
  • (no location specified)
Feb 7, 2022

Stress Response, Multitasking Behavior, Mental Stress Trial (100% Cranberry Juice, 100% Cranberry Juice + 200 mg L-theanine,

Not yet recruiting
  • Stress Response
  • +5 more
  • 100% Cranberry Juice
  • +2 more
  • (no location specified)
Sep 27, 2023

Covid19 Trial in South Pasadena (KELEA Excellerated Water, Water Without an Elevated Level of KELEA)

Active, not recruiting
  • Covid19
  • KELEA Excellerated Water
  • Water Without an Elevated Level of KELEA
  • South Pasadena, California
    Institute of Progressive Medicine
Aug 5, 2022

Suspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria Trial (LPS Adsorber)

Not yet recruiting
  • Suspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria
  • LPS Adsorber
  • (no location specified)
Feb 18, 2022

Negative Symptom, Schizophrenia, Amisulpride Trial (Amisulpride)

Unknown status
  • Negative Symptom
  • +3 more
  • (no location specified)
Aug 26, 2020

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Chronic Schizophrenia Trial in Baoding (Magstim RAPID2 neuromagnetic stimulator (Magstim) with an "8"-type coil)

Completed
  • Chronic Schizophrenia
  • Magstim RAPID2 neuromagnetic stimulator (Magstim) with an "8"-type coil
  • Baoding, Hebei, China
    Rongjun Hospital of Hebei Province Affiliated to North China Uni
Mar 30, 2023

Schizophrenia Negative Type Trial in Tianjin (tDCS active stimulation combined with rTMS sham stimulation, rTMS active

Enrolling by invitation
  • Schizophrenia Negative Type
  • tDCS active stimulation combined with rTMS sham stimulation
  • +3 more
  • Tianjin, Tianjin, China
    Jie Li
Jan 14, 2023

Using Speech to Monitor Symptom Severity in Arabic Speaking

Recruiting
  • Schizophrenia
  • WinterLight Mobile Phone Speech Analysis
  • Algiers, Algeria
  • +3 more
Sep 28, 2022

Negative Symptoms in Schizophrenia Trial (Metacognitive Training for Negative Symptoms (MCT), Supportive Counselling)

Not yet recruiting
  • Negative Symptoms in Schizophrenia
  • Metacognitive Training for Negative Symptoms (MCT)
  • Supportive Counselling
  • (no location specified)
Nov 6, 2023

Hallucinations, Verbal Auditory Trial in Aachen (procedure, behavioral, other)

Completed
  • Hallucinations, Verbal Auditory
  • fMRI
  • +4 more
  • Aachen, Germany
    University Hospital RWTH Aachen, Department of Psychiatry, Psych
Jan 7, 2020

Depression, Schizophrenia Trial in Aachen (procedure, behavioral, other)

Completed
  • Depression
  • Schizophrenia
  • fMRI
  • +4 more
  • Aachen, Germany
    University Hospital RWTH Aachen, Department of Psychiatry, Psych
Dec 6, 2019

Schizophrenia, Schizoaffective Disorder Trial in Worldwide (RO6889450, Placebo)

Recruiting
  • Schizophrenia, Schizoaffective Disorder
  • Bellflower, California
  • +65 more
Feb 2, 2023

Schizophrenia Trial in Changsha (Intermittent theta burst stimulation, Sham stimulation)

Recruiting
  • Schizophrenia
  • Intermittent theta burst stimulation
  • Sham stimulation
  • Changsha, Hunan, China
    Second Xiangya Hospital
Nov 27, 2022

Schizophrenia Trial in Worldwide (Luvadaxistat, Placebo)

Completed
  • Schizophrenia
  • Garden Grove, California
  • +53 more
Dec 7, 2021

Schizophrenia, Cannabis Use Disorder Trial (Delta-9-THC, Placebo)

Not yet recruiting
  • Schizophrenia
  • Cannabis Use Disorder
  • (no location specified)
Sep 21, 2023

Schizophrenia, Negative Symptoms Trial in Lauderdale Lakes, Grand Rapids, Glen Oaks (Vortioxetine, Placebo)

Recruiting
  • Schizophrenia
  • Negative Symptoms
  • Lauderdale Lakes, Florida
  • +2 more
Apr 4, 2022

Coronavirus Disease 2019 Trial in Shanghai (Huashi Baidu granule, compound pholcodine oral solution)

Completed
  • Coronavirus Disease 2019
  • Huashi Baidu granule
  • compound pholcodine oral solution
  • Shanghai, Shanghai, China
    Shanghai children's medical center
Aug 15, 2022

Disclosing Cancer Predisposition Genetic Testing Results During

Recruiting
  • Pediatric Cancer
  • Predisposition, Genetic
    • Memphis, Tennessee
      St.Jude Children's Research Hospital
    Nov 28, 2022

    Schizophrenia Spectrum and Other Psychotic Disorders Trial in Lørenskog (Vitamin D, Placebo)

    Recruiting
    • Schizophrenia Spectrum and Other Psychotic Disorders
    • Vitamin D
    • Placebo
    • Lørenskog, Norway
      Akershus University Hospital, Division of Psychiatry
    Apr 8, 2022

    Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo)

    Recruiting
    • Schizophrenia
    • Xanomeline and Trospium Chloride Capsules
    • Placebo
    • Little Rock, Arkansas
    • +18 more
    Aug 12, 2022

    MDD, Recurrent, in Remission Trial (Negative ion therapy, Light therapy)

    Not yet recruiting
    • Major Depressive Disorder, Recurrent, in Remission
    • Negative ion therapy
    • Light therapy
    • (no location specified)
    Jul 19, 2022

    Schizophrenia Trial in Moscow, Village Nikolskoe (LY2140023, olanzapine, )

    Completed
    • Schizophrenia
    • Moscow, Russian Federation
    • +1 more
    Aug 16, 2021

    Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia Trial (Aripiprazole 10 MG)

    Not yet recruiting
    • Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
    • Aripiprazole 10 MG
    • (no location specified)
    Mar 10, 2023